Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Multiple Myeloma 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Follicular 6Lymphoma 6Myelodysplastic Syndromes 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Acute 5Leukemia 5Neoplasms, Plasma Cell 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, B-Cell, Marginal Zone 4Hodgkin Disease 4Dendritic Cell Sarcoma, Interdigitating 4Burkitt Lymphoma 4Thrombocythemia, Essential 3Recurrence 3Primary Myelofibrosis 3Myeloproliferative Disorders 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Accelerated Phase 3Leukemia, Lymphocytic, Chronic, B-Cell 3Graft vs Host Disease 3Sezary Syndrome 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Polycythemia Vera 2Mycosis Fungoides 2

Interventions

fludarabine phosphate 2Polymerase Chain Reaction 2Flow Cytometry 2tipifarnib 1romidepsin 1motexafin gadolinium 1Vorinostat 1Thiotepa 1Therapeutics 1Tetradecanoylphorbol Acetate 1Tacrolimus 1Sunitinib 1Peripheral Blood Stem Cell Transplantation 1Methylprednisolone 1Melphalan 1MK 2206 1In Situ Hybridization, Fluorescence 1Immunologic Techniques 1Immunohistochemistry 1Immunoenzyme Techniques 1Imatinib Mesylate 1Filgrastim 1Fenretinide 1Etoposide 1Doxorubicin 1Decitabine 1Cytarabine 1Cyclophosphamide 1Cord Blood Stem Cell Transplantation 1Cefepime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Leukemia, Neutrophilic, Chronic × Methylprednisolone × Clear all
NCT00054236 2020-07-27

Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia

Case Comprehensive Cancer Center

Phase 1 Completed
55 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Leukemia, Erythroblastic, Acute, Hodgkin Disease, Leukemia, Leukemia, Megakaryoblastic, Acute, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡